Spyre Therapeutics (NASDAQ:SYRE [https://seekingalpha.com/symbol/SYRE]) announced the pricing [https://seekingalpha.com/pr/20263812-spyre-therapeutics-announces-pricing-of-275_0-million-public-offering-of-common-stock] of its previously [https://seekingalpha.com/news/4503705-spyre-therapeutics-announces-public-offering-of-common-stock-and-pre-funded-warrants] disclosed underwritten public offering, to offer 14,864,865 shares of common stock at a public price of $18.50 per share.
Spyre expects to raise approximately $275.0 million in gross proceeds from this offering.
Furthermore, the company has granted the underwriters a 30-day option to purchase up to an additional 2,229,729 shares of common stock at the public offering price.
The offering is anticipated to close on or about October 15, 2025.
MORE ON SPYRE THERAPEUTICS
* Intelligent Development Could Make Spyre Therapeutics Best In Show [https://seekingalpha.com/article/4824265-intelligent-development-could-make-spyre-therapeutics-stock-best-in-show]
* Spyre Therapeutics announces public offering of common stock and pre-funded warrants [https://seekingalpha.com/news/4503705-spyre-therapeutics-announces-public-offering-of-common-stock-and-pre-funded-warrants]
* Seeking Alpha’s Quant Rating on Spyre Therapeutics [https://seekingalpha.com/symbol/SYRE/ratings/quant-ratings]
* Historical earnings data for Spyre Therapeutics [https://seekingalpha.com/symbol/SYRE/earnings]
* Financial information for Spyre Therapeutics [https://seekingalpha.com/symbol/SYRE/income-statement]
Spyre Therapeutics prices public offering of 14.8M shares at $18.50 to raise $275M
Published 4 weeks ago
Oct 14, 2025 at 6:28 AM
Positive
Auto